TheProfitWatch

ABOS - Acumen Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.34 -0.15 (-6.41%) --- --- 0.0 (0.0%) 0.01 (0.31%) -0.06 (-2.55%) 0.0 (0.0%) 0.0 (0.0%)

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.68
Diluted EPS:
-0.68
Basic P/E:
-3.2206
Diluted P/E:
-3.2206
RSI(14) 1m:
0.0
VWAP:
2.19
RVol:

Events

Period Kind Movement Occurred At

Related News